“There’s No Way”: One Year to Bring Treatment to Children in Taiwan
- Corporate
SHIONOGI Journal
全14件
A World-Class Two-Way Player Brings Fresh Energy to a Storied Tradition
- Corporate
Delivering Safe, Trustworthy Medicines for Children ーInside SHIONOGI’s RSV Drug Discoveryー
- Research
Taking on the Challenge of Untreatable Conditions: Toward a “Future of Hearing” Through Drug Discovery
- Research
The Power to Create Medicines That Reach Patients—Passing SHIONOGI’s Baton of Innovation to the Next Generation
- Research
Facing Patients Beyond Prescriptions: The Mission and Challenges of the Frontline Medical Information Center
- MR
Significance of SHIONOGI’s Challenge in the “Resource Recycle Project”
- Manufacturing
Merging with the US biotech venture Qpex: A chronicle of striving for the integration process aimed at maximizing value
- Corporate
Striving for Palliative Care that Leaves No One Behind: Aiming for a Communication Barrier-Free Reality
- MR
SHIONOGI’s Commitment to Antibiotics: Aiming for an Ideal Collaboration between Industry, Government, and Academia to Tackle Infectious Diseases
- Corporate
“Pharmaceutical Education” by Virtual Employee
- New Business
Embracing the Challenge of Societal “Issues”: A Young Challenger Looks Beyond the Walls
- New Business
Leveraging Real-world Data and Artificial Intelligence: The Story Behind the Outstanding Leadership Award
- DX
Researchers on One Health and the Proper Use of Medications: Behind the Scenes of Rare Species Conservation and Infectious Disease Control
- Research